Generate a tailored SOP for Dr. Lu Wang. Improve your application with a focused, well-structured draft.
Lu Wang's laboratory focuses on the misregulation of histone and DNA modifiers as common therapeutic targets for treating human diseases, particularly cancer. They employ advanced technologies, including genome-wide CRISPR screening and high-throughput small-molecule inhibitor screening, to explore the relationship between dysregulated epigenetic factors and cancer development. Through this research, they aim to identify the druggability of specific epigenetic factors, paving the way for novel and precise cancer treatments that can be translated into clinical applications. Lu obtained a Ph.D. from Nanjing University in 2011 and completed postdoctoral fellowships at the University of Wisconsin, Madison, and Northwestern University, focusing on epigenetics and breast cancer as well as general cancer research. He has received several notable awards highlighting his contributions to cancer research.
Northwestern University Feinberg School of Medicine • Chicago, Illinois
Focus on the relationship between dysregulated epigenetic factors and cancer development.
Administered by The Graduate School; focuses on Biomechanics, Imaging, Biomaterials, and Regenerative Medicine.